
    
      To healthy subjects of twenty-four (24), following treatments are administered dosing in each
      period and wash-out period is a minimum of 7 days.

      Reference drug: 1) CKD-501 0.5mg 2) D759 3) D150 Test drug: 1) CKD-393 0.5/100/1000mg
      formulation Ⅰ Tab. 2) CKD-393 0.5/100/1000mg formulation Ⅱ Tab.

      Pharmacokinetic blood samples are collected up to 48hrs. The pharmacokinetic characteristics
      and safety are assessed.
    
  